Dose regimen doses of aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Blood Platelets Gastric Mucosa Liver Kidney

Organisms7

Gammapapillomavirus Rats, Sprague-Dawley Rats, Wistar Dogs Mice, Inbred BALB C Rabbits Rats, Inbred Strains

Diseases28

Malaria, Falciparum Recurrence Hemorrhage Asthma, Aspirin-Induced Neoplasms Gastrointestinal Hemorrhage Thrombosis Disease Models, Animal Myocardial Infarction Neutropenia Stomach Ulcer Nausea Drug Hypersensitivity Lung Neoplasms Stroke Vomiting HIV Infections Body Weight Colorectal Neoplasms Radiation Injuries Acute Disease Gastrointestinal Diseases Breast Neoplasms Reye Syndrome Cardiovascular Diseases Thrombocytopenia Leukopenia Thromboembolism

Chemicals and Drugs74

Aspirin Fluorenes Antimalarials Artemisinins Platelet Aggregation Inhibitors Drug Combinations Anti-Inflammatory Agents, Non-Steroidal Anti-Bacterial Agents Anti-Infective Agents Antineoplastic Agents Ticlopidine Recombinant Proteins Thromboxane B2 Cyclooxygenase Inhibitors Salicylates Cyclophosphamide Anticoagulants Warfarin Sodium Salicylate Fibrinolytic Agents Tablets, Enteric-Coated Doxorubicin Ibuprofen Acetaminophen Fluorouracil Cisplatin Cyclooxygenase 1 Prostaglandin-Endoperoxide Synthases Vincristine Thromboxanes Cyclooxygenase 2 Inhibitors Thromboxane A2 Dipyridamole Etoposide Immunosuppressive Agents Placebos Prednisone Anti-HIV Agents Antibodies, Monoclonal Methotrexate Deoxycytidine Paclitaxel Cyclooxygenase 2 Prostaglandins Sulfonamides Heparin Lipoxins Delayed-Action Preparations Sulfinpyrazone Anti-Ulcer Agents Naproxen Dinoprostone Indomethacin Leucovorin Anti-Inflammatory Agents Cytarabine Vinblastine Pyrazoles Antineoplastic Agents, Phytogenic Epoprostenol Prednisolone Carboplatin Taxoids Organoplatinum Compounds Camptothecin Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Analgesics, Non-Narcotic Salicylic Acid Quinolines Analgesics Ifosfamide 6-Ketoprostaglandin F1 alpha Busulfan

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Drug Administration Schedule Double-Blind Method Treatment Outcome Administration, Oral Drug Therapy, Combination Injections, Intravenous Area Under Curve Infusions, Intravenous Metabolic Clearance Rate Clinical Trials as Topic Prospective Studies Cross-Over Studies Follow-Up Studies Radiation Dosage Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Microbial Sensitivity Tests Platelet Function Tests Radiometry Dose Fractionation Radiotherapy Dosage Dose-Response Relationship, Radiation Combined Modality Therapy Retrospective Studies Risk Factors Survival Analysis Drug Evaluation Bleeding Time Random Allocation Randomized Controlled Trials as Topic Injections, Subcutaneous Radiotherapy Planning, Computer-Assisted Survival Rate Disease Models, Animal Disease-Free Survival Treatment Failure Cohort Studies Placebos Injections, Intramuscular Risk Assessment Remission Induction Body Burden Premedication Thermoluminescent Dosimetry Body Weight Delayed-Action Preparations Analysis of Variance Salvage Therapy Single-Blind Method Incidence Blood Pressure Chromatography, High Pressure Liquid Prognosis Transplantation Conditioning Metered Dose Inhalers Radiation Monitoring Immunization, Secondary Whole-Body Irradiation Administration, Inhalation Injections, Intraperitoneal Chemoprevention Radiotherapy, Intensity-Modulated Models, Biological Risk Hematopoietic Stem Cell Transplantation

Psychiatry and Psychology1

Patient Compliance

Phenomena and Processes20

Dose-Response Relationship, Drug Time Factors Area Under Curve Half-Life Metabolic Clearance Rate Pregnancy Radiation Dosage Lethal Dose 50 Platelet Aggregation Drug Interactions Dose-Response Relationship, Radiation Drug Resistance Bleeding Time Platelet Activation Drug Synergism Biological Availability Body Weight Blood Pressure Drug Tolerance Risk

Information Science4

Radiotherapy Planning, Computer-Assisted Survival Rate Incidence Radiotherapy, Intensity-Modulated

Named Groups1

Infant, Newborn

Health Care30

Double-Blind Method Treatment Outcome Area Under Curve Clinical Trials as Topic Prospective Studies Cross-Over Studies Follow-Up Studies Radiation Dosage Dose-Response Relationship, Radiation Retrospective Studies Risk Factors Survival Analysis Random Allocation Randomized Controlled Trials as Topic Survival Rate Disease-Free Survival Treatment Failure Cohort Studies Risk Assessment Body Burden Thermoluminescent Dosimetry Patient Compliance Radiation Injuries Relative Biological Effectiveness Analysis of Variance Single-Blind Method Incidence Radiation Monitoring Primary Prevention Risk

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Named Groups Health Care

Aspirin Drug Administration Schedule Dose-Response Relationship, Drug Double-Blind Method Treatment Outcome Administration, Oral Gammapapillomavirus Drug Therapy, Combination Fluorenes Injections, Intravenous Time Factors Antimalarials Area Under Curve Half-Life Artemisinins Platelet Aggregation Inhibitors Drug Combinations Infusions, Intravenous Anti-Inflammatory Agents, Non-Steroidal Metabolic Clearance Rate Clinical Trials as Topic Prospective Studies Anti-Bacterial Agents Malaria, Falciparum Anti-Infective Agents Antineoplastic Agents Recurrence Cross-Over Studies Follow-Up Studies Pregnancy Ticlopidine Recombinant Proteins Thromboxane B2 Radiation Dosage Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Cyclooxygenase Inhibitors Platelet Aggregation Microbial Sensitivity Tests Salicylates Infant, Newborn Platelet Function Tests Radiometry Drug Interactions Blood Platelets Cyclophosphamide Dose Fractionation Anticoagulants Radiotherapy Dosage Hemorrhage Warfarin Dose-Response Relationship, Radiation Sodium Salicylate Combined Modality Therapy Retrospective Studies Risk Factors Drug Resistance Fibrinolytic Agents Survival Analysis Tablets, Enteric-Coated Doxorubicin Drug Evaluation Ibuprofen Acetaminophen Fluorouracil Cisplatin Bleeding Time Asthma, Aspirin-Induced Neoplasms Random Allocation Cyclooxygenase 1 Prostaglandin-Endoperoxide Synthases Gastrointestinal Hemorrhage Randomized Controlled Trials as Topic Vincristine Platelet Activation Thrombosis Injections, Subcutaneous Drug Synergism Rats, Sprague-Dawley Thromboxanes Cyclooxygenase 2 Inhibitors Radiotherapy Planning, Computer-Assisted Survival Rate Thromboxane A2 Disease Models, Animal Dipyridamole Etoposide Disease-Free Survival Immunosuppressive Agents Treatment Failure Cohort Studies Placebos Prednisone Anti-HIV Agents Biological Availability Antibodies, Monoclonal Myocardial Infarction Injections, Intramuscular Neutropenia

No FAQ available that match "dose regimen doses of aspirin"